March 2014

Volume 22 Issue 3

Editorial Staff

Clinical Editor
Morton Kern, MD
Executive Editor
Laurie Gustafson
Managing Editor
Rebecca Kapur
Production Manager
Elizabeth Vasil

Editorial Correspondence

Rebecca Kapur, Managing Editor, Cath Lab Digest
HMP Communications, 70 E. Swedesford Rd
Suite 100, Malvern PA 19355
Telephone: (440) 717-0418

Fax: (866) 896-8762
Intercoronary anastomosis should not be confused with collateral arteries, which have distinct angiographic features and underlying pathophysiological mechanisms.
Data from animal studies and clinical trials in humans suggests that the introduction of stem cells and/or specific genes into the heart can improve outcomes. However, results have been mixed.
Email notice of credentialing, job changes, promotions, etc., to us at This month, Cath Lab Digest would like to congratulate….
Our facility is comprised of three labs: one dedicated electrophysiology (EP) lab and two diagnostic/interventional labs. Construction of our new hybrid lab began in the first quarter of 2014.
In light of recent technological developments and surprising pivotal clinical trial results, the future of renal denervation took a surprisingly tenuous turn in early 2014.
Herein, we present a case of a single coronary artery arising from the right coronary cusp and selective engagement of each coronary artery with the use of a single diagnostic catheter via the transradial approach.
The science of RDN had made noteworthy progress and yet with Medtronic’s announcement that its SYMPLICITY-3 (S-3) trial did not meet the predefined effectiveness endpoint dampened enthusiasm and, rightfully so, put a pause on the sprint of RDN.
Quality cardiovascular patient care should ensure that the right patient has the right procedure with the right execution resulting in the right outcome, as benchmarked by the NCDR.
The Vascular Center of Colorado (VCC) recently engaged in a successful agreement to purchase coronary drug eluting stents (DES) with a market share commitment to a single vendor.